Bicarbonate

Bicarbonate

SCHEMBL2485672

O=C(O)O.O=C(O)O.[La].[La]

nearest known ligand 0.83

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Bicarbonate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.83
CA2 P00918 1/20 0.83
CA9 Q16790 1/20 0.83
FFAR3 O14843 2/20 0.44
ACHE P22303 1/20 0.44
LCK P06239 1/20 0.44
FYN P06241 1/20 0.44
TSHR P16473 4/20 0.36
LMNA P02545 3/20 0.36
LDHA P00338 2/20 0.36
EGLN1 Q9GZT9 2/20 0.36
LDHB P07195 1/20 0.36
SRR Q9GZT4 1/20 0.36
TP53 P04637 1/20 0.36
ALKBH5 Q6P6C2 1/20 0.36
SUCNR1 Q9BXA5 1/20 0.36
EGLN3 Q9H6Z9 1/20 0.36
OR51E2 Q9H255 2/20 0.33
GLRA1 P23415 1/20 0.33
SLC6A9 P48067 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bicarbonate SCHEMBL28455789 1.00
Bicarbonate SCHEMBL9274418 1.00
Bicarbonate SCHEMBL40505 1.00
Bicarbonate SCHEMBL72938 0.93
Bicarbonate SCHEMBL22476040 0.93 CA1 (0.71) CA1CA2CA9FFAR3ACHE
Bicarbonate SCHEMBL153475 0.93 CA1 (0.71) CA1CA2CA9FFAR3ACHE
Bicarbonate SCHEMBL150901 0.93
Bicarbonate SCHEMBL21815628 0.93
Bicarbonate SCHEMBL2487509 0.93 CA1 (0.71) CA1CA2CA9FFAR3ACHE
Bicarbonate SCHEMBL150637 0.93

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108530289-A A kind of preparation method of lanthanum acetate 乐山沃耐稀电子材料有限公司 2018-09-14 CN disclosed
EP-2645995-A1 CAPSULE AND POWDER FORMULATIONS CONTAINING LANTHANUM COMPOUNDS Shire LLC (US) 2013-10-09 EP disclosed
WO-2012075194-A1 CAPSULE AND POWDER FORMULATIONS CONTAINING LANTHANUM COMPOUNDS SHIRE LLC (US) 2012-06-07 WO disclosed
EP-1852695-B1 Assay for lanthanum hydroxy carbonate SHIRE INT LICENSING BV (NL) 2011-10-26 EP disclosed
US-20100092576-A1 PHARMACEUTICAL COMPOSITIONS CONTAINING LANTHANUM HYDROXYCARBONATE SHIRE INTERNATIONAL LICENSING B.V. (NL) 2010-04-15 US disclosed
US-7618656-B2 Method for use of lanthanum carbonate pharmaceutical compositions SHIRE INTERNATIONAL LICENSING B.V. (NL) 2009-11-17 US disclosed
US-20080089948-A1 METHOD OF USE FOR LANTHANUM CARBONATE AND LANTHANUM HYDROXYCARBONATE SHIRE INTERNATIONAL LICENSING B.V. (NL) 2008-04-17 US disclosed
WO-2007130721-A2 ASSAY FOR LANTHANUM HYDROXYCARBONATE SHIRE INTERNATIONAL LICENSING B.V. (NL) 2007-11-15 WO disclosed
US-20070259052-A1 Assay for lanthanum hydroxycarbonate SHIRE INTERNATIONAL LICENSING B.V. (NL) 2007-11-08 US disclosed
EP-1852695-A1 Assay for lanthanum hydroxy carbonate Shire International Licensing B.V. (NL) 2007-11-07 EP disclosed